Lexicon Pharmaceuticals Inc. (LXRX) Event Aug. 03, 2022, 00:00 UTC (75% Positive) Lexicon Pharmaceuticals, Inc. (LXRX) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:44 a.m. 🏢 Lexicon Pharmaceuticals Inc. (LXRX) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-03 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-39.02M $-48.06M $9.04M +18.80% 📉 Total Assets $136.91M $112.33M $24.58M +21.89% 📈 Total Liabilities $23.31M $41.49M $-18.18M -43.81% 📈 Stockholders' Equity $113.59M $70.83M $42.77M +60.38% 📈 Operating Income/Loss $-38.80M $-47.39M $8.59M +18.13% 📉 R&D Expense $22.87M $28.28M $-5.42M -19.15% 📈 Earningspersharebasic $-0.27 $-0.32 $0.05 +15.62% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Lexicon Pharmaceuticals Inc. (LXRX) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document